Engineers Gate Manager’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Engineers Gate Manager’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17,178	Closed	-$346K	–	2398
2021 Q3	$346K	Sell	17,178 -3,829	-18%	-$106K	0.02%	1107
2021 Q2	$784K	Sell	21,007 -183	-0.9%	-$5.61K	0.05%	548
2021 Q1	$542K	Sell	21,190 -9,470	-31%	-$242K	0.03%	934
2020 Q4	$675K	Buy	+30,660	New	+$675K	0.03%	793
2020 Q1	–	Sell	-27,812	Closed	-$613K	–	2062
2019 Q4	$613K	Buy	+27,812	New	+$560K	0.03%	888

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Engineers Gate Manager's DRNA Position: Q4 2021 in Review

Engineers Gate Manager sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 17,178 shares — an estimated $346K sold.

Engineers Gate Manager first reported a position in DRNA in Q4 2019 and held it in 5 quarters. The position peaked at $784K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Engineers Gate Manager reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Engineers Gate Manager sold 17,178 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $346K.
Engineers Gate Manager first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 5 quarters.
Engineers Gate Manager's Dicerna Pharmaceuticals, Inc. position peaked at $784K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Engineers Gate Manager's 13F filing for Q4 2021, filed 14 Feb 2022.